271 related articles for article (PubMed ID: 23385039)
1. Phenothiazine-type antipsychotics may attenuate naloxone-precipitated withdrawal jumping in morphine-dependent mice.
Wu SZ; Chen KT; Chen JY; Sung KC; Wang JJ; Liu KS; Chu CC
Acta Anaesthesiol Taiwan; 2012 Dec; 50(4):167-71. PubMed ID: 23385039
[TBL] [Abstract][Full Text] [Related]
2. A dose-response study on the efficacy of tricyclic antidepressants on reducing morphine-withdrawal symptoms.
Liu KS; Chen SJ; Chen YW; Sung KC; Wang JJ
Acta Anaesthesiol Taiwan; 2013 Mar; 51(1):18-21. PubMed ID: 23711601
[TBL] [Abstract][Full Text] [Related]
3. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
[TBL] [Abstract][Full Text] [Related]
4. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
Li T; Hou Y; Cao W; Yan CX; Chen T; Li SB
Neurosci Lett; 2010 Jan; 468(3):348-52. PubMed ID: 19922770
[TBL] [Abstract][Full Text] [Related]
5. Acutely administered clozapine does not modify naloxone-induced withdrawal jumping in morphine-dependent mice.
Ballard TM; McAllister KH
Pharmacol Biochem Behav; 1999 Feb; 62(2):285-90. PubMed ID: 9972695
[TBL] [Abstract][Full Text] [Related]
6. Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms.
Pałucha A; Brański P; Pilc A
Pol J Pharmacol; 2004; 56(6):863-6. PubMed ID: 15662102
[TBL] [Abstract][Full Text] [Related]
7. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
Zarrindast MR; Mohajeri S
Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
9. Modulation of src-kinase attenuates naloxone-precipitated opioid withdrawal syndrome in mice.
Rehni AK; Singh N
Behav Pharmacol; 2011 Apr; 22(2):182-90. PubMed ID: 21285874
[TBL] [Abstract][Full Text] [Related]
10. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
[TBL] [Abstract][Full Text] [Related]
11. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
Azizi H; Ranjbar-Slamloo Y; Semnanian S
Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
[TBL] [Abstract][Full Text] [Related]
12. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade.
Hamdy MM; Noda Y; Miyazaki M; Mamiya T; Nozaki A; Nitta A; Sayed M; Assi AA; Gomaa A; Nabeshima T
Behav Brain Res; 2004 Jul; 152(2):263-70. PubMed ID: 15196794
[TBL] [Abstract][Full Text] [Related]
14. Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice.
Tan-No K; Sato T; Shimoda M; Nakagawasai O; Niijima F; Kawamura S; Furuta S; Sato T; Satoh S; Silberring J; Terenius L; Tadano T
Neuropeptides; 2010 Jun; 44(3):279-83. PubMed ID: 20189644
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
Mamiya T; Noda Y; Ren X; Hamdy M; Furukawa S; Kameyama T; Yamada K; Nabeshima T
Br J Pharmacol; 2001 Mar; 132(5):1111-7. PubMed ID: 11226142
[TBL] [Abstract][Full Text] [Related]
16. Blockade by narcotic drugs of naloxone-precipitated jumping in morphine-dependent mice.
Iorio LC; Deacon MA; Ryan EA
J Pharmacol Exp Ther; 1975 Jan; 192(1):58-63. PubMed ID: 1168251
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.
Singh P; Sharma B; Gupta S; Sharma BM
Psychopharmacology (Berl); 2015 Jan; 232(2):465-75. PubMed ID: 25059539
[TBL] [Abstract][Full Text] [Related]
18. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
Hodgson SR; Hofford RS; Norris CJ; Eitan S
Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
[TBL] [Abstract][Full Text] [Related]
19. Effects of polyinosinic-polycytidylic acid (Poly I:C) on naloxone-precipitated withdrawal in morphine-dependent mice.
Chen L; Zhai H; Lu L; Chen S; Ning Y; Wang W
Neurosci Lett; 2011 Jan; 487(3):341-4. PubMed ID: 20974220
[TBL] [Abstract][Full Text] [Related]
20. Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline.
Way EL; Iwamoto ET; Khanna S; Ho IK; Shen F; Loh HH
J Pharmacol Exp Ther; 1976 Nov; 199(2):400-7. PubMed ID: 10429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]